Smart Inhalers Market is expected to reach US$ 8,033.21 Million by 2027

Asthma Segment to Hold Major Smart Inhalers Market Share During 2018–2027 

According to our latest study on “Smart Inhalers Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product, Disorder, End User, and Geography”. The global smart inhalers market is expected to reach US$ 8,033.21 Mn by 2027 from US$ 1,094.26 in 2018. The smart inhalers market is estimated to grow with a CAGR of 25.5% from 2018-2027. Increasing levels of air pollution in countries as France, Brazil, and others as well as rise in the smoking habits among individuals in India, Italy, Germany, UAE, etc. Rising prevalence of asthma and COPD across the globe and growing geriatric population in regions such as Asia, Europe and North America are expected to boost are the key driving factors for the growth of the market in the forecast period. However, the smart inhalers market growth is restrained by factors such as limited knowledge regarding the use of smart inhalers and the risks associated with cyber threats.

Global smart inhalers market, based on disorder was segmented into asthma and chronic obstructive pulmonary disease. In 2018, the asthma segment held the largest share of the market. In addition, segment is also expected to grow at the fastest rate during the coming years owing to rising prevalence of asthma among the developed as well as developing economies. Asthma is a chronic disease of the airways that transport air to and from the lungs. In this condition, the airways narrow and swell producing extra mucus, which leads to difficulty in breathing and triggers coughing, wheezing and shortness of breath. Complete cure for asthma isn’t available, however its symptoms can be controlled. The symptoms of asthma vary from person to person, ranging from mild to severe. Some of the common symptoms of asthma include, shortness of breath, chest pain or tightness, extreme coughing or whistling or wheezing sounds.

If the intensity of the symptoms is much severe due to a set of inflammatory events in the respiratory system is known as an asthma attack. Worldwide, around 250,000 people die every year as a result of asthma. At present around 235 million people currently suffer from asthma. In addition, according to the latest WHO estimates, released in December 2016, there were approximately 383 000 deaths due to asthma in 2015. The rising prevalence of the disorder as well as the increasing mortality rate of asthma is anticipated to fuel the demand for the smart inhalers market in the segment during the forecast period.

Global smart inhalers market, based on product was segmented nebulizers and inhalers. In 2018, the inhalers segment held the largest share of the market, by product. In addition, segment is also expected to grow at the fastest rate during the coming years owing to as inhalers are available in various forms and are used as per the severity of the disease. Inhalers are the devices used for delivery of medications in respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). Some of the main types of inhalers used in asthma and COPD are, manually-actuated pressurized metered-dose inhalers, breath-actuated pressurized metered-dose inhalers, dry powder inhalers, and mist inhalers. The use of an inhaler highly depends on the intensity of the respiratory disorder and the need for its diagnosis. With the help of a metered dose inhaler, the medication has a better chance to reach the small airways, thus increasing the medication's effectiveness. A dry powder inhaler (DPI) is generally used to deliver medications such as inhaled corticosteroids into the lungs. A DPI is breath activated and hence the medication is released only when an individual takes a deep, fast breath in through the inhaler. Some of the medications commonly delivered are beta-agonists, anticholinergics, glucocorticoids, tobramycin, and insulin.

Global smart inhalers market, based on end user was segmented into home-care settings and hospitals & clinics. In 2018, the home-care settings segment held the largest share of the market. In addition, segment is also expected to grow at the fastest rate during the coming years since, smart inhalers enable patients to efficiently manage of asthma and COPD, this also helps the physicians to provide better diagnosis as well as treatment of the patient’s medical condition. Smart inhalers are being developed for the treatment of respiratory disorders such as asthma and COPD. Smart inhalers as compared to the traditional ones have extra digital features through which they are able to link to an app on one’s mobile device or tablet. This helps the doctors to efficiently manage a patient’s asthma or COPD. Certain smart inhalers also are equipped with sensors which send reminders and also alert a user of a high pollen area. These features make smart inhalers a highly preferred choice among users as well as physicians, since they help in better management of patient’s health. Also, during recent years there has been a significant rise in the cases of asthma and COPD across the globe. Also, these devices are connected digitally, enabling the patients to get advice from their physicians, even when situated far. Hence, owing to the above mentioned factors, the demand for smart inhalers is anticipated to witness significant growth in the segment during the forecast period.

GlaxoSmithKline plc; Adherium Limited; Novartis AG; Vectura Group plc; Cohero Health, Inc.; Crux Product Design Ltd; Findair Sp. z o. o.; Teva Pharmaceutical Industries Ltd.; 3M; Amiko Digital Health Limited are among the several players engaged in addressing the demands for smart inhalers market growth. 

The report segments the Smart Inhalers market as follows:
Based on product, the smart inhalers market is bifurcated into nebulizers and inhalers. Based on application, the smart inhalers market is segmented into chronic obstructive pulmonary disease (COPD) and asthma. Based on end user, the smart inhalers market is segmented into home-care settings and hospitals & clinics. Based on geography, the smart inhalers market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com